prodigiosin has been researched along with Staphylococcal-Infections* in 3 studies
3 other study(ies) available for prodigiosin and Staphylococcal-Infections
| Article | Year |
|---|---|
The effectiveness of antimicrobial photodynamic therapy with prodigiosin against reference strains of Staphylococcus aureus, Escherichia coli, and Pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacteria; Escherichia coli; Humans; Photochemotherapy; Prodigiosin; Pseudomonas aeruginosa; Staphylococcal Infections; Staphylococcus aureus | 2022 |
A Compound Inhibits Biofilm Formation of Staphylococcus aureus from Streptomyces.
Biofilm is one virulence factor of bacteria. It contributes not only to bacterial adherence to many kinds of infection-establishing surfaces, but also to bacterial resistance against antimicrobial agents and antiseptic agents. Thus, inhibitors of bacterial biofilm formation should be useful in the prevention of infections. We found that a culture of Streptomyces sp. strain MC11024 showed inhibitory activity on biofilm formation by Staphylococcus aureus and isolated streptorubin B as an inhibitor of this formation in S. aureus. The biofilm formation of methicillin resistant S. aureus (MRSA) N315 was reduced to less than 30% at 1 µg/mL of streptorubin B, and at this concentration cell growth was not affected. Our study suggests that streptorubin B has the potential to be a leading compound of anti-infectious agents of S. aureus. Topics: Anti-Bacterial Agents; Biofilms; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Microbial Interactions; Microbial Sensitivity Tests; Prodigiosin; Staphylococcal Infections; Streptomyces | 2015 |
[Endogenic infectious diseases and and prospects of their treatment].
Topics: Adult; Bacterial Infections; Biological Products; Complement System Proteins; Enterocolitis, Pseudomembranous; Female; Hepatitis A; Humans; Intestines; Leukocytes; Middle Aged; Muramidase; Prodigiosin; Sepsis; Staphylococcal Infections | 1975 |